FMI Scientific Advisory Board
The Scientific Advisory Board assists the Director and the group leaders by reviewing research programs and advising on policy and scientific matters. All of the board members are prominent experts in the field of biomedical research.
The FMI Scientific Advisory Board is appointed by the Novartis Research Foundation for 3 year terms.
Current board members are:
Prof. C. David Allis
The Rockefeller University, New York, USA
» More information
Prof. Lewis C. Cantley
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
» More information
Prof. Aaron Ciechanover
Technion-Israel Institute of Technology, Haifa, Israel
» More information
Prof. Gideon Dreyfuss (Chairperson)
Howard Hughes Medical Institute, Philadelphia, USA
» More information
Prof. Catherine Dulac
Howard Hughes Medical Institute, Cambridge, USA
» More information
Dr. Anne Ephrussi
EMBL Heidelberg, Heidelberg, Germany
» More information
Dr. Tony Pawson
Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto, Canada
» More information
Dr. Jeff Porter
Novartis Institutes for BioMedical Research, Cambridge, USA
» More information
Prof. Martin E. Schwab
University of Zurich and Swiss Federal Institute of Technology, Zurich, Switzerland
» More information